In research published this week in PLoS Medicine Stephen Lim and colleagues (University of Washington) systematically estimate the changes in distribution of insecticide-treated bed nets (ITNs) across Africa between 2000 and 2008, and find that several countries have managed to scale up their ITN

read more>>

Global initiatives to control specific diseases, such as polio or worm diseases, in low income countries not only do goodSometimes they pull people and resources away from basic health care. Then the remedy may be worse than the disease. In an article in the open-access journal PLoS Neglected Trop

read more>>

B vitamins–B-6, B-12 and folate–all nourish the brainBut much remains to be discovered about the relation between these essential nutrients and our brainpowerU.S. Department of Agriculture (USDA) nutritionist Lindsay H. Allen has collaborated in ongoing research that has taken a close

read more>>

Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the Company will participate in the

read more>>

SAN FRANCISCO -- The Juvenile Diabetes Research Foundation wants every Bay Area parent to be "T1D Aware" and recognize the telltale signs of type 1 diabetes in order to prevent a potentially deadly complication that often occurs as a result of a delayed diagnosisJDRF is launching the new education

read more>>

Melbourne, Australia -- Australian regenerative medicine company, Mesoblast Limited (ASX:MSB; ADR:MBLTY), today provided market guidance on its Phase 3 bone marrow transplant program following a formal meeting with the United States Food and Drug Administration (FDAFor this Phase 3 program, the pa

read more>>

EXTON, Pa. -- Morphotek(R),Inc., a subsidiary of Eisai Inc., announced today that the John Wayne Cancer Institute in Santa Monica, California has opened enrollment in a Phase I clinical study with MORAb-028 in patients with advanced melanomaMORAb-028 is a fully human recombinant IgM-type antibody.

read more>>

Geneva -- With an agreement signed today, MMV (Medicines for Malaria Venture)became the first product development partnership (PDP) to contribute intellectual property to the Pool for Open Innovation Against Neglected Tropical DiseasesThe Pool was established in February 2009 by GSK (GlaxoSmithKli

read more>>

SACRAMENTO, Calif. -- The Sacramento Board of Supervisors, including Roger Dickinson, Chair, have partnered with the California School Nurses Organization (CSNO), Sacramento County Department of Health and Human Services, and Sacramento Healthy Community Immunization Coalition, to declare August 16

read more>>

The Buck Institute for Age Research (Buck) announced today that it has entered into a research collaboration with BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to evaluate therapeutic approaches for treatment of early onset Familial Alzheimer’s Disease (eFAD), an autosomal dominant form of eFA

read more>>